Logo image of GCTS

GCT SEMICONDUCTOR HOLDING IN (GCTS) Stock Fundamental Analysis

USA - NYSE:GCTS - US36170N1072 - Common Stock

1.31 USD
-0.03 (-2.24%)
Last: 11/21/2025, 8:04:00 PM
Fundamental Rating

1

Taking everything into account, GCTS scores 1 out of 10 in our fundamental rating. GCTS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. GCTS may be in some trouble as it scores bad on both profitability and health. GCTS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GCTS had negative earnings in the past year.
GCTS had a negative operating cash flow in the past year.
GCTS Yearly Net Income VS EBIT VS OCF VS FCFGCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

1.2 Ratios

GCTS has a Return On Assets of -185.02%. This is amonst the worse of the industry: GCTS underperforms 96.43% of its industry peers.
Industry RankSector Rank
ROA -185.02%
ROE N/A
ROIC N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTS Yearly ROA, ROE, ROICGCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

GCTS has a Gross Margin (43.93%) which is in line with its industry peers.
The Profit Margin and Operating Margin are not available for GCTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTS Yearly Profit, Operating, Gross MarginsGCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

GCTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GCTS has more shares outstanding
The debt/assets ratio for GCTS has been reduced compared to a year ago.
GCTS Yearly Shares OutstandingGCTS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GCTS Yearly Total Debt VS Total AssetsGCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -54.61, we must say that GCTS is in the distress zone and has some risk of bankruptcy.
GCTS has a worse Altman-Z score (-54.61) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -54.61
ROIC/WACCN/A
WACC11.21%
GCTS Yearly LT Debt VS Equity VS FCFGCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

GCTS has a Current Ratio of 0.21. This is a bad value and indicates that GCTS is not financially healthy enough and could expect problems in meeting its short term obligations.
GCTS has a Current ratio of 0.21. This is amonst the worse of the industry: GCTS underperforms 98.21% of its industry peers.
A Quick Ratio of 0.17 indicates that GCTS may have some problems paying its short term obligations.
The Quick ratio of GCTS (0.17) is worse than 98.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.17
GCTS Yearly Current Assets VS Current LiabilitesGCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

GCTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -105.02%.
GCTS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.93%.
EPS 1Y (TTM)-105.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1073.99%
Revenue 1Y (TTM)-31.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.48%

3.2 Future

Based on estimates for the next years, GCTS will show a very strong growth in Earnings Per Share. The EPS will grow by 33.75% on average per year.
Based on estimates for the next years, GCTS will show a very strong growth in Revenue. The Revenue will grow by 106.53% on average per year.
EPS Next Y-160%
EPS Next 2Y15.47%
EPS Next 3Y37.51%
EPS Next 5Y33.75%
Revenue Next Year-55.9%
Revenue Next 2Y173.63%
Revenue Next 3Y140.22%
Revenue Next 5Y106.54%

3.3 Evolution

GCTS Yearly Revenue VS EstimatesGCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 50M 100M 150M
GCTS Yearly EPS VS EstimatesGCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GCTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GCTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTS Price Earnings VS Forward Price EarningsGCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTS Per share dataGCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as GCTS's earnings are expected to grow with 37.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y37.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GCTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GCT SEMICONDUCTOR HOLDING IN

NYSE:GCTS (11/21/2025, 8:04:00 PM)

1.31

-0.03 (-2.24%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-23 2026-03-23
Inst Owners14.61%
Inst Owner Change-15.08%
Ins Owners3.87%
Ins Owner Change9.58%
Market Cap73.18M
Revenue(TTM)6.07M
Net Income(TTM)-32.60M
Analysts82.86
Price Target4.08 (211.45%)
Short Float %4.06%
Short Ratio5.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-64.57%
Min EPS beat(2)-82.07%
Max EPS beat(2)-47.06%
EPS beat(4)2
Avg EPS beat(4)-24.77%
Min EPS beat(4)-82.07%
Max EPS beat(4)28.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-61.83%
Min Revenue beat(2)-74.04%
Max Revenue beat(2)-49.62%
Revenue beat(4)1
Avg Revenue beat(4)-17.87%
Min Revenue beat(4)-74.04%
Max Revenue beat(4)66.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-72.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-83.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-80.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.11
BVpS-1.25
TBVpS-1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -185.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.93%
FCFM N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 209.46%
Cap/Sales 10.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.17
Altman-Z -54.61
F-Score2
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1073.99%
EPS Next Y-160%
EPS Next 2Y15.47%
EPS Next 3Y37.51%
EPS Next 5Y33.75%
Revenue 1Y (TTM)-31.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.48%
Revenue Next Year-55.9%
Revenue Next 2Y173.63%
Revenue Next 3Y140.22%
Revenue Next 5Y106.54%
EBIT growth 1Y-44.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-150.72%
EBIT Next 3Y50.34%
EBIT Next 5Y45.33%
FCF growth 1Y-834.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-810.23%
OCF growth 3YN/A
OCF growth 5YN/A

GCT SEMICONDUCTOR HOLDING IN / GCTS FAQ

What is the fundamental rating for GCTS stock?

ChartMill assigns a fundamental rating of 1 / 10 to GCTS.


What is the valuation status of GCT SEMICONDUCTOR HOLDING IN (GCTS) stock?

ChartMill assigns a valuation rating of 1 / 10 to GCT SEMICONDUCTOR HOLDING IN (GCTS). This can be considered as Overvalued.


How profitable is GCT SEMICONDUCTOR HOLDING IN (GCTS) stock?

GCT SEMICONDUCTOR HOLDING IN (GCTS) has a profitability rating of 0 / 10.


Can you provide the financial health for GCTS stock?

The financial health rating of GCT SEMICONDUCTOR HOLDING IN (GCTS) is 0 / 10.